Medtronic recalls nearly 350,000 implantable heart devices after 22 injuries
The FDA has categorized this as a Class I recall, meaning the use of these devices could cause “serious injuries or death.”
Related Articles
‘A compelling alternative’: Polymer heart valve receives first commercial approval of its kind
A new surgical mitral valve from Foldax will now be commercially available in India. The valve is built using LifePolymer, a proprietary material that does not…
Judge triples damages in antitrust lawsuit, ordering Johnson & Johnson MedTech to pay $442M
A bad outcome for Johnson & Johnson MedTech just got significantly worse. A jury previously ordered the company to pay $147M, but a judge just…
TAVR specialists come together to explore new data, patient selection and much more
Care teams have a lot to consider when choosing the right treatment for patients with severe aortic stenosis. Two cardiologists and a veteran cardiothoracic surgeon are…
How anticoagulants may impact a patient’s risk of gastrointestinal bleeding after TAVR
Researchers tracked the rates of major gastrointestinal bleeding in patients with AFib randomized to receive edoxaban or a vitamin K antagonist after a successful TAVR procedure.
TAVR for Today’s Patient: Updates on Data, Risk, Anatomy, and Access
Listen in as a general cardiologist, surgeon, and interventionalist delve into the latest evidence—including the Evolut™ TAVR 5-Year Low Risk data and SMART Trial 2-Year…
Heart surgeons perform world’s first robotic TAVR explant and aortic valve replacement
The patient, 67, presented with a failing TAVR valve and a leaky mitral valve. She had undergone TAVR four years prior, but premature structural valve…
Congenital heart surgeon named president of the American Association for Thoracic Surgery
Emile Bacha, MD, is an internationally recognized leader in both pediatric and adult congenital cardiac surgery.
Cardiologist became paralyzed after wearing heavy aprons in the cath lab for decades—but he fought back
Dean J. Kereiakes, MD, was left paralyzed after battling severe orthopedic issues for his entire career. Back in the cath lab after a long recovery,…
Real-world data favor SAVR over TAVR when younger patients need aortic valve replacement
Researchers in Italy tracked data from more than 7,000 patients who underwent AVR between the ages of 65 and 80. TAVR was associated with a…
Tiny clot-busting robots could transform care for stroke and heart attack patients
The robots are capable of swimming through a patient’s vascular system and removing blood clots. “It’s unbelievable,” one Stanford researcher said. “This is a sea-change technology…